- Home
- SCTX vs MVBF Comparison
SCTX vs MVBF Comparison
Compare SCTX & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCTX | MVBF |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.2M | 335.2M |
| IPO Year | 2026 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SCTX | MVBF |
|---|---|---|
| Price | $16.15 | $25.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $57.00 | $30.50 |
| AVG Volume (30 Days) | ★ 346.2K | 62.4K |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 2.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $3,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.88 |
| P/E Ratio | ★ N/A | $18.99 |
| Revenue Growth | N/A | ★ 51.92 |
| 52 Week Low | $13.50 | $23.99 |
| 52 Week High | $39.60 | $31.99 |
Technical Indicators
Market Signals| Indicator | SCTX | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 30.61 |
| Support Level | $13.90 | $24.41 |
| Resistance Level | $22.07 | $26.60 |
| Average True Range (ATR) | 1.58 | 1.20 |
| MACD | 0.33 | -0.14 |
| Stochastic Oscillator | 52.49 | 1.04 |
Price Performance
Historical ComparisonAbout SCTX Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
About MVBF MVB Financial Corp.
MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.